Sima P. Porten
- Urology top 0.5%
- Urological Disorders and Treatments 13
- Surgery top 0.5%
- Bladder and Urothelial Cancer Treatments 100
- Urinary and Genital Oncology Studies 63
- Esophageal Cancer Research and Treatment 8
-
- Prostate Cancer Diagnosis and Treatment 15
- Prostate Cancer Treatment and Research 15
- Oncology top 2%
- Cancer Immunotherapy and Biomarkers 13
- Immunology top 5%
-
- Epigenetics and DNA Methylation 15
- Co-authors
- Maxwell V. MengColin P. DinneyArlene O. Siefker‐RadtkeDavid J. McConkeyBogdan CzerniakDaniel WillisPeter R. CarrollMatthew R. Cooperberg
- Partner nations
- United StatesCanadaUnited Kingdom
In The Last Decade
Sima P. Porten
127 papers receiving 4.3k citations
Hit Papers
Peers
Comparison fields: 5 of 112
- Urology 559
- Surgery 2.9k
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.2k
- Immunology 461
Countries citing papers authored by Sima P. Porten
This map shows the geographic impact of Sima P. Porten's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sima P. Porten with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sima P. Porten more than expected).
Fields of papers citing papers by Sima P. Porten
This network shows the impact of papers produced by Sima P. Porten. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sima P. Porten. The network helps show where Sima P. Porten may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sima P. Porten, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 1 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 48 | |
| 5 | 2023 | 1 | |
| 6 | 2023 | 3 | |
| 7 | 2022 | 56 | |
| 8 | 2021 | 101 | |
| 9 | 2020 | 6 | |
| 10 | 2020 | 8 | |
| 11 | 2020 | 2 | |
| 12 | 2020 | 1 | |
| 13 | 2019 | 109 | |
| 14 | 2019 | 12 | |
| 15 | 2018 | 18 | |
| 16 | 2013 | 1 | |
| 17 | 2012 | 13 | |
| 18 | 2011 | 149 | |
| 19 | 2010 | 219 | |
| 20 | 2010 | 16 |
About Sima P. Porten
Sima P. Porten is a scholar working on Urology, Surgery and Complementary and Manual Therapy, having authored 137 papers that have together received 4.3k indexed citations. Recurring topics across this work include Bladder and Urothelial Cancer Treatments (100 papers), Urinary and Genital Oncology Studies (63 papers), Prostate Cancer Diagnosis and Treatment (15 papers), Epigenetics and DNA Methylation (15 papers), Prostate Cancer Treatment and Research (15 papers), Cancer Immunotherapy and Biomarkers (13 papers), Urological Disorders and Treatments (13 papers) and Esophageal Cancer Research and Treatment (8 papers). The work is most often cited by research in Urology (559 citations), Surgery (2.9k citations) and Pulmonary and Respiratory Medicine (1.4k citations). Sima P. Porten has collaborated with scholars based in United States, Canada and United Kingdom. Frequent co-authors include Maxwell V. Meng, Colin P. Dinney, Arlene O. Siefker‐Radtke, David J. McConkey, Bogdan Czerniak, Daniel Willis, Peter R. Carroll, Matthew R. Cooperberg, Woonyoung Choi and Shanna Pretzsch. Their work appears in journals such as Cell, Nature Communications and Journal of Clinical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.